Peer Review History
| Original SubmissionJanuary 26, 2026 |
|---|
|
PESY-D-26-00009 A protocol for biodiversity-informed wildlife disease surveillance PLOS Ecosystems Dear Dr. Catchen, Thank you for submitting your manuscript to PLOS Ecosystems. After careful consideration, we feel that it has merit but does not fully meet PLOS Ecosystems's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 60 days May 31 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at customercare@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pesy/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Carolyn J. Lundquist, PhD Section Editor PLOS Ecosystems Henrique M. Pereira Editor-in-Chief PLOS Ecosystems Journal Requirements: 1. Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published. i. Please clarify all sources of financial support for your study. List the grants, grant numbers, and organizations that funded your study, including funding received from your institution. Please note that suppliers of material support, including research materials, should be recognized in the Acknowledgements section rather than in the Financial Disclosure. ii. State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)." iii. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” iv. If any authors received a salary from any of your funders, please state which authors and which funders. 2. We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. 3. Please upload separate figure files in .tif or .eps format. Also, remove the figures from your manuscript file but keep the legends. For more information about figure files please see our guidelines: https://journals.plos.org/ecosystems/s/figures https://journals.plos.org/ecosystems/s/figures#loc-file-requirements 4. Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150–200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines: https://journals.plos.org/ecosystems/s/submission-guidelines#loc-parts-of-a-submission 5. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 6. Some material included in your submission may be copyrighted. According to PLOS’s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOS’s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form. Please respond directly to this email or email the journal office and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Potential Copyright Issues: a. Figure 1: Please confirm whether you drew the images / clip-art within the figure panels by hand. If you did not draw the images, please provide (a) a link to the source of the images or icons and their license / terms of use; or (b) written permission from the copyright holder to publish the images or icons under our CC-BY 4.0 license. Alternatively, you may replace the images with open source alternatives. See these open source resources you may use to replace images / clip-art: - https://commons.wikimedia.org b. Figures 2, 3, 4 and Figure 1 in supplement.pdf: please (a) provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and (b) provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC-BY 4.0 license. Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted. If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC-BY 4.0 license. Please note that the following CC BY licenses are compatible with PLOS license: CC BY 4.0, CC BY 2.0 and CC BY 3.0, meanwhile such licenses as CC BY-ND 3.0 and others are not compatible due to additional restrictions. If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps: * U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov) * PlaniGlobe - All maps are published under a Creative Commons license so please cite “PlaniGlobe, http://www.planiglobe.com, CC BY 2.0” in the image credit after the caption. (http://www.planiglobe.com/?lang=enl) * Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/) Additional Editor Comments (if provided): We have received two external reviews of your manuscript, both of which highlight the novelty and usefulness of the proposed protocol. Both provide detailed feedback, noting one provides feedback primarily within an annotated copy of the manuscript of suggested revisions to enhance the quality of the manuscript. We welcome a revision of your manuscript that addresses these comments. [Note: HTML markup is below. Please do not edit.] Reviewers' Comments: Reviewer's Responses to Questions Comments to the Author 1. Does this manuscript meet PLOS Ecosystems’s publication criteria?> Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously?-->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I have all of my comments on the attached PDF. But to summarize the strengths of the manuscript: • I appreciate the idea of identifying sampling priorities while explicitly incorporating spatial uncertainty. Overall, I see this as a promising step forward in environmental risk mapping. • While species weighting always involves assumptions and caveats, I applaud the authors for trying to bring more nuance to weighing decisions (eg serology vs PCR). In many modeling frameworks, weighting decisions are left to the modeler’s discretion and can feel somewhat ad hoc. The ePort to provide a more structured approach is commendable. • I found the distinction between sampling location and type of data sampled to be particularly insightful • The conceptual distinction between hazard and risk is also useful and clearly framed I was able to clone the repository and run part of the code. Without troubleshooting or actively fixing errors, I was able to run the India case study but not the South Korea case study. I initially suspected the issue might relate to OSM object, but it appears to be unrelated. However, I am primarily an R user, so this could reflect my own skillset rather than an issue with the repository itself. If may be helpful for the authors to ask another primarily R user to test the workflow on a different machine. Reviewer #2: Developing surveillance systems for wildlife pathogens continues to be a tricky problem in the field of One Health due to the presence of many unknowns and the unavoidable constraints in sampling. One cannot sample all species all at once, so there must be some prioritization system. The authors of this manuscript have proposed a method for designing wildlife pathogen surveillance systems that stakeholders could use to better target some of the uncertainties about hosts or pathogen prevalence in a given area. The protocol appears to be ideal for use in an evolving information environment, where new host or prevalence can be added to the underlying model to create the next iteration of sampling prioritization. The manuscript followed a somewhat unusual format for a research article, but it worked well for how the content was presented, as an introduction to the concepts and the model, then a demonstration using two case studies. The boxes provided some additional useful information about how to interpret species distribution models and the recommended sampling locations outputted from the model. Overall, I think this protocol could be an excellent addition to the field. The manuscript text was clear and the figures illustrated some of the key outputs and concepts discussed in the text, such that users could refer back to this manuscript to help with interpretation of their own output. I did not have any major concerns about the model, though I did think there were many places where some additional explanation about how choices are made about species weights and other model variables would be valuable for potential users. One other general comment: would it be useful to have a glossary of terms somewhere in the manuscript or supplement? There are some esoteric terms that get used throughout the paper and are defined in the text, but a centralized location for these terms could help readers with comprehension. Key terms may include: risk, hazard, spillover, biosurveillance, discovery sampling, prevalence sampling, Biodiversity Observation Network, biodiversity dose. L19-20: Expand on this statement a little to provide more justification. As it stands now, this seems like a fairly empty proclamation. However, the first paragraph of Section 2 does a fantastic job with distinguishing hazard from risk and justifying why biosurveillance is a key part of estimating hazard. Pulling in some of that nuance here would make a stronger case. L32: Hyphen not needed in Arenaviridae. Also make sure to italicize virus family names. Lastly, and this may be pedantic, but “small mammals” or “rodents and shrews” would be better than rodents here and throughout the paper. Suncus murinus and Crocidura lasiura are shrews (Eulipotyphla), not rodents. And I think broadly the hantaviruses can infect both taxa, so you should be as inclusive as possible, even if arenaviruses are more specific to rodents. L34-35: This is more of a general comment, but it was not immediately clear how this protocol would get used in the public health space. Who are the intended users of this protocols and how would the information about sampling and testing be distributed to stakeholders? Do you think this is a purely academic exercise, or is it intended that governments and agencies would be leading these efforts? It may be worth some additional discussion at the end of the paper to make the strong case to specific end users. L124-127: Why is this considered part of risk? As laid out in the sections above, this seems more in line with hazard rather than risk, because risk is largely driven by anthropogenic activities, no? Changes in the host side of things seem like they would have more influence on hazard than risk. L184-185: Unclear which of the methods is the one with higher false-negatives. One would initially guess that PCR has the higher false-negative rate because of the frequently short window of pathogen shedding, such that it may be difficult to find a host actively shedding, even if they are ultimately a competent host. Whereas with serology, one runs the risk of including many noncompetent hosts that have simply been exposed but the pathogen does not replicate in or transmit from this host. So those would be false-positives in the eyes of many ecologists. This question seems like it would also have a fairly large influence on the model uncertainty. Is this something that needs to be included in sensitivity analyses? And is there a way of incorporating uncertainty in host weights into the calculation of biodiversity dose, beyond just random noise, but a more specific way of quantifying differences in uncertainty among host species? L199: What about prevalence uncertainty? If a small sample at a location showed high prevalence, it does not mean it is always that high and is likely biased. This location would have high prevalence uncertainty (10/1000 has less uncertainty than 1/100). Is there any way to include prevalence uncertainty into this model, e.g., weighting inversely by sample size? If it is already included in the model, a short section explaining how it is done would be helpful. L213: Could the authors provide more guidance about how all these uncertainties about host competence and prevalence get boiled down into w_{i}? Is there an equation that could be built to estimate w_{i}, or are the values based solely on investigator judgement? L281-283: Could you also apply this to investigate the sensitivity of maps to changes in weights that do indeed reflect biological differences in host relevance, such as when one doesn’t know whether all species are equally competent hosts? Would there need to be something larger than small “nudges” to the weights? L300-L303: Maybe indicate that the South Korea case study is about hosts of Hantaviridae. It’s not currently stated explicitly here. L308-309: If there is no prevalence or sampling data in some locations, how can one be sure about which hosts are contributing to pathogen maintenance? Are there potentially unknown host species that need to be accounted for? And how would one go about assigning weights to these species? L335-338: I understand what is trying to be done here with this case study, but it sort of falls short of being a great example of how one might approach this type of low information sampling. This seems from a glance to be just an assortment of relatively common species in India. The authors might have to provide a disclaimer that the species chosen by Rodrigues may be different than what would have been chosen by an alternative method that uses all available biodiversity information and phylogenetic proximity to known hosts. L338: What were the chosen weights? Which species ended up with the highest weight in the images shown in Figure 2? L348-349: What is the process for deciding the tilting value alpha? What sort of behavior in the model is “ideal” and how would a user decide? L359: What is the justification for including Imjin virus here? Is there any evidence that this virus can or does infect humans? Or is this operating from a pure hazard viewpoint that any hantavirus in a host can potentially cause human infections? And what do we know about the role of these species in transmission? Are they the only hosts, or just the dominant hosts? How many additional species contribute to hantavirus transmission in South Korea that are not included in this case study? L363-366: If the authors were performing this case study as a real analysis or sample planning exercise, what sort of sensitivity analyses would the authors suggest running to incorporate additional known hosts and other potential hosts with unknown status? L384: Similar comment as above, how was the tilting value alpha chosen for this case study? L481-483: The way I thought about this was in terms of additive probabilities. Because the presence of species are not mutually exclusive, their additive probabilities would be P(A or B) = P(A) + P(B) – P(A and B). However, since P(A and B) requires a joint SDM to estimate, it does not get subtracted off in the probability estimate and therefore we get an overestimate of sympatry between two species. And obviously this gets compounded when you stack an even larger number of potential sympatric species. ********** what does this mean? ). If published, this will include your full peer review and any attached files. Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public. For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript. Reproducibility: ?>
|
| Revision 1 |
|
A protocol for biodiversity-informed wildlife disease surveillance PESY-D-26-00009R1 Dear Dr Catchen, We are pleased to inform you that your manuscript 'A protocol for biodiversity-informed wildlife disease surveillance' has been provisionally accepted for publication in PLOS Ecosystems. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow-up email from a member of our team. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact customercare@plos.org. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Ecosystems. Best regards, Carolyn J. Lundquist, PhD Section Editor PLOS Ecosystems Henrique M. Pereira Editor-in-Chief PLOS Ecosystems *********************************************************** Thank you for submitting the revised version of the manuscript which was reviewed by one of the original reviewers, who agreed that the feedback had been adequately addressed. The reviewer noted a few minor typos that the editorial staff can determine if a further round of revisions is required or if these can be addressed in the final copy editing stage. Reviewer Comments (if any, and for reference): Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) ********** Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously?-->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: The authors have adequately addressed all comments raised in the previous round of review. I have only a few minor comments. 1. Correct spelling and grammar: “prevantative” (L24) to “preventative”, “disperate” (L92) to “disparate”, “substatially” (L94) to “substantially”, “about about” (L224) to “about”, “phyologenies” (L237) to “phylogenies”, “that” (L288) to “than”, “Hantaviridea” (L443) to “Hantaviridae”. 2. Correct sentence: “…an essential to confidence this protocol…” (L242), appears that several words are missing. Maybe correct to “…an essential step to build confidence that this protocol…”? 3. Reference all Supplemental Material: It doesn’t look like Supplemental Fig. 1 or Supplemental Table 3 are mentioned by name anywhere in the text. The authors should insert references to these items into the main text where appropriate. It might be useful to mention the Glossary early on in the text once some of the selected terms have been introduced. ********** what does this mean? ). If published, this will include your full peer review and any attached files. Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public. For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .